Название продукции:Triphenylmethyl chloride
- CAS:76-83-5
- Молекулярная формула:C19H15Cl
- Чистота:95%+
- Номер в каталоге:CM000181
- Молекулярная масса:278.78
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:76-83-5
- Молекулярная формула:C19H15Cl
- Точка плавления:-
- Smiles-код:ClC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
- Плотность:
- Номер в каталоге:CM000181
- Молекулярная масса:278.78
- Точка кипения:
- Номер Mdl:MFCD00000813
- Хранение:
Column Infos
- Zegocractin
- CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.